I42.4 Endocardial fibroelastosis

Name of the Condition

• Endocardial Fibroelastosis (ICD-10 Code: I42.4)

Summary

Endocardial fibroelastosis is a rare heart condition characterized by the thickening of the endocardium, the inner lining of the heart chambers, due to excessive fibrous and elastic tissue. This thickening can impair heart function, particularly in infants and young children, leading to heart failure or other complications.

Causes

The exact cause of endocardial fibroelastosis is not fully understood, but it may be associated with viral infections (such as mumps or coxsackievirus), genetic factors, or maternal conditions during pregnancy. In some cases, it occurs secondary to other heart defects or systemic diseases.

Risk Factors

• Family history of congenital heart disease.
• Exposure to certain viral infections during pregnancy or early infancy.
• Underlying genetic syndromes or chromosomal abnormalities.
• Maternal health conditions, such as diabetes or infections, during pregnancy.

Symptoms

• Rapid breathing or shortness of breath.
• Poor feeding or failure to thrive in infants.
• Swelling in the abdomen or legs (edema).
• Fatigue or lethargy.
• Irregular heartbeat (arrhythmia) or palpitations.
• Cyanosis (bluish skin discoloration) in severe cases.

Diagnosis

Diagnosis typically involves a physical exam, review of medical history, and imaging tests such as an echocardiogram to assess heart structure and function. Additional tests, including electrocardiograms (ECG) or cardiac MRI, may be used to evaluate electrical activity or tissue characteristics. Blood tests or genetic testing may also be considered to rule out underlying causes.

Treatment Options

• Medications to manage heart failure, such as diuretics, ACE inhibitors, or beta-blockers.
• Supportive care, including oxygen therapy or nutritional support for infants.
• Surgical interventions, such as valve repair or heart transplantation, in severe cases.
• Ongoing monitoring and management of associated complications.

Prognosis and Follow-Up

Prognosis varies depending on the severity of the condition and the age of onset. Early diagnosis and treatment can improve outcomes, but some cases may progress to chronic heart failure or require long-term care. Regular follow-up with a cardiologist is essential to monitor heart function and adjust treatment as needed.

Complications

• Progressive heart failure.
• Arrhythmias or irregular heart rhythms.
• Blood clots leading to stroke or other vascular events.
• Developmental delays in infants due to poor circulation.
• Increased risk of sudden cardiac death in severe cases.

Lifestyle & Prevention

• Maintain a heart-healthy diet low in sodium and saturated fats.
• Avoid exposure to known viral infections during pregnancy or early infancy.
• Follow recommended vaccination schedules to reduce infection risk.
• Engage in regular physical activity as advised by a healthcare provider.
• Monitor and manage chronic conditions like hypertension or diabetes.

When to Seek Professional Help

Seek immediate medical attention if you or your child experience sudden shortness of breath, chest pain, fainting, or severe fatigue. Regular check-ups are recommended for individuals with a family history of heart disease or related symptoms.

Tips for Medical Coders

When coding for endocardial fibroelastosis (I42.4), ensure documentation supports the diagnosis, including clinical findings, imaging results, or specialist evaluations. Note any associated conditions or complications that may require additional codes. Verify the specificity of the diagnosis to avoid miscoding, and confirm that the code aligns with the patient's documented clinical presentation.